The story ofAPNEAL is written in the wake of a bold vision: transforming medical diagnosis through accessible and innovative technology. Founded in 2021, this young French start-up has carved out a place of choice in the world of MedTech, offering a revolutionary solution for sleep analysis. Using the simple power of a smartphone, APNEAL makes sleep apnea screening possible for millions of people, without constraints or unnecessary waiting. With its medical device ready to integrate into everyone’s daily life, APNEAL, crowned by prestigious programs such as EIT Health Flagships, embodies the future of healthtech, where innovation rhymes with accessibility.

APNEAL is a French start-up which stands out for its ambition to revolutionize the diagnosis of sleep apnea. Founded in 2021, this DeepTech and MedTech company puts accessibility and innovation at the heart of its mission. In just three years, she has had a remarkable impact on how patients can diagnose possible sleep disorders.

Imagine a world where each person, simply with their smartphone, can carry out a medical examination to detect sleep apnea without waiting. APNEAL makes this possible, offering an innovative medical device which uses today’s technology to improve tomorrow’s health. This innovation has been praised by many players in the field, notably winning the prestigious first prize at international events.

Recognition and opportunities were not long in coming for APNEAL, which was selected to participate in the European EIT Health Flagships program. This recognition opens new perspectives for this start-up, always determined to put technology at the service of health. Through alliances and a forward-looking vision, APNEAL continues to grow and influence the medtech.

an innovative vision at the heart of medtech

Founded in 2021, APNEAL has marked the medtech sector with a revolutionary approach in the diagnosis of sleep disorders. In just two years, this French start-up has become a key player by integrating technology deeptech to simplify and optimize the diagnostic journey. This innovative approach was designed to eliminate the usual complex procedures and introduce easier access to diagnosis through the use of a smartphone. This innovative medical device allows users to perform sleep examinations directly from home, greatly reducing waiting times for patients.

The international recognition of APNEAL is undeniable. After being selected to participate in the prestigious program EIT Health Flagships, APNEAL has managed to attract the attention of global summits in biotechnology and medical innovation. Collaborations with entities like Bio Europe and the Bio International Convention demonstrate the scale of its influence and its potential to redefine the interface between technology and medical diagnosis. Building on its success, the start-up also won first prize inEIT Health, thus cementing its place among the pioneers of medical innovation.

technology for well-being

By questioning traditional methods, APNEAL has been able to take advantage of the latest technological advances to develop a accessible solution for all. This easy-to-use medical device detects sleep apnea using a user-friendly application available on smartphones, a major step forward in improving patients’ quality of life. To know more, you can visit the official website of APNEAL.

Not content with only innovating in diagnosis, the start-up is also part of a global public health approach by collaborating with associations and major players in the sector to raise awareness among the general public. The support of France Biotech, an influential organization championing the voice of start-ups in medical technology, ensures that APNEAL remains at the forefront of innovation and continues to deliver solutions that revolutionize the medical background.

a journey marked by success and distinctions

APNEAL is not just another start-up. By ranking among the 1st PROMOTION OF STARTUPS selected by Cortexx Medical Intelligence, the company demonstrates its potential and ability to transform trials into tangible successes. THE industrial fabric rich in Medtech offers APNEAL fertile ground for innovation, and each distinction received demonstrates the added value it brings to the medical field.